Latest / Breastcancer.org Podcast
Top Research From SABCS 2025
The 2025 San Antonio Breast Cancer Symposium featured four days filled with new research findings, poster presentations, and educational sessions. Marisa Weiss, MD, founder and chief medical officer of Breastcancer.org, offers her take on the top results.
Listen to the episode to hear Dr. Weiss explain:
how giredestrant, a new oral SERD for early-stage, hormone receptor-positive breast cancer, may change practice
a new use for Tukysa (chemical name: tucatinib) in metastatic HER2-positive disease
the lifestyle factors that can affect breast cancer risk and steps people can take to keep their…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.